Play all audios:
The degree to which the elevated risk of malignant lymphomas in patients with rheumatoid arthritis (RA) is related to disease activity or to therapy is uncertain. Evidence is mounting in
support of a strategy of more-intensive cancer screening in these patients. Access through your institution Buy or subscribe This is a preview of subscription content, access via your
institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this
article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in
* Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Askling, J., Klareskog, L., Blomqvist, P., Fored, M. & Feltelius, N. Risk for malignant
lymphoma in ankylosing spondylitis: a nationwide Swedish case–control study. _Ann. Rheum. Dis._ 65, 1184–1187 (2006). Article CAS PubMed PubMed Central Google Scholar * Stern, R. S.
Lymphoma risk in psoriasis: results of the PUVA follow-up study. _Arch. Dermatol._ 142, 1132–1135 (2006). PubMed Google Scholar * Askling, J. _ et al_. Anti-tumour necrosis factor therapy
in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. _Ann. Rheum. Dis._ 68, 648–653 (2009). Article CAS PubMed Google
Scholar * Askling, J. _ et al_. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. _Ann. Rheum. Dis._ 66, 1339–1344
(2007). Article PubMed PubMed Central Google Scholar * Bongartz, T. _ et al_. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: a
systematic review and meta-analysis of rare harmful effects in randomized clinical trials. _JAMA_ 295, 2275–2285 (2006). Article CAS Google Scholar * Bongartz, T. _ et al_. Etanercept
therapy in rheumatoid arthritis and the risk of malignancies. A systematic review and individual patient data meta-analysis of randomized controlled trials. _Ann. Rheum. Dis._ 68, 1177–1183
(2009). Article CAS PubMed Google Scholar * Nannini, C. _ et al_. Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid
arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures? _Arthritis Rheum._
61, 801–812 (2009). Article CAS PubMed Google Scholar * Wolfe, F. & Michaud, K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy
in 18,572 patients. _Arthritis Rheum._ 50, 1740–1751 (2004). Article CAS PubMed Google Scholar * Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N. & Klareskog, L. Disease activity
and risk of lymphoma in patients with rheumatoid arthritis: nested case–control study. _BMJ_ 317, 180–181 (1998). Article CAS PubMed PubMed Central Google Scholar * Hellgren, K. _ et
al_. Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas—results from a case–control study. _Ann. Rheum. Dis._ doi:10.1136/ard.2008.096925. Article PubMed
Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Division of Rheumatology, Mayo Clinic School of Medicine, Rochester, MN, USA Eric L. Matteson Authors *
Eric L. Matteson View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Eric L. Matteson. ETHICS DECLARATIONS COMPETING
INTERESTS The author declares that he has acted as a consultant for and received research support from the following companies: Abbot, Amgen, Centocor and Wyeth. In addition, the author has
received research support from the following companies: Genentech and Bristol Myers Squibb. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Matteson, E.
Should cancer screening be routine in rheumatoid arthritis?. _Nat Rev Rheumatol_ 5, 474–475 (2009). https://doi.org/10.1038/nrrheum.2009.173 Download citation * Issue Date: September 2009 *
DOI: https://doi.org/10.1038/nrrheum.2009.173 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative